Patient Capital Management’s JD.com JD Stock Holding History

Patient Capital Management’s Portfolio JD Stock Details JD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.1M	Sell	1,377,719 -21,749	-2%	-$641K	1.15%	31
2026 Q1	$41.4M	Buy	1,399,468 +558,483	+66%	+$15.8M	1.51%	28
2025 Q4	$24.1M	Sell	840,985 -1,952	-0.2%	-$61K	0.93%	31
2025 Q3	$29.5M	Buy	842,937 +53,810	+7%	+$1.75M	1.18%	32
2025 Q2	$25.8M	Buy	789,127 +3,207	+0.4%	+$109K	1.16%	30
2025 Q1	$32.3M	Buy	785,920 +685,920	+686%	+$27.5M	1.66%	29
2024 Q4	$3.47M	Buy	+100,000	New	+$3.87M	0.16%	36

Other funds holding JD

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

NMO

Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

NOSC

North of South Capital London, United Kingdom $1.36B AUM 26.43% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Discerene Group Stamford, Connecticut $889M AUM 1.91% 1-Year Est. Return

SAG

Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $5.75B AUM 39.93% 1-Year Est. Return

Patient Capital Management's JD Position: Q2 2026 in Review

Patient Capital Management reduced its JD.com (JD) stake by 1.6% in Q2 2026, selling an estimated $641K and leaving 1,377,719 shares worth $35.1M. The position accounts for 1.15% of the portfolio, ranked #31.

Patient Capital Management first reported a position in JD in Q4 2024 and has held it in 7 quarters since. The position peaked at $41.4M in Q1 2026. 426 funds tracked by Wall St. Rank hold JD as of Q2 2026.

Patient Capital Management held 1,377,719 shares of JD.com worth $35.1M as of Q2 2026.
Patient Capital Management sold 21,749 JD.com shares in Q2 2026, an estimated $641K.
JD.com made up 1.15% of Patient Capital Management's portfolio in Q2 2026, its #31 holding.
Patient Capital Management first reported a position in JD.com in Q4 2024 and has held it in 7 quarters since.
Patient Capital Management's JD.com position peaked at $41.4M in Q1 2026.
426 funds tracked by Wall St. Rank held JD.com as of Q2 2026.

Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.